Name
Session IV: Resistance to Immunotherapy (Novel vs Clinically Approved)
Date & Time
Tuesday, June 23, 2026, 10:20 AM - 11:50 AM
Speakers
Andy Minn, MD, PhD, Memorial Sloan Kettering Cancer Center
Marcel van den Brink, MD, PhD, City of Hope
Nicholas Arpaia, PhD, Columbia University Irving Medical Center
Susan Bullman, PhD, MD Anderson Cancer Center
Marcel van den Brink, MD, PhD, City of Hope
Nicholas Arpaia, PhD, Columbia University Irving Medical Center
Susan Bullman, PhD, MD Anderson Cancer Center
Description
Chairperson: Andy Minn, MD, PhD, Memorial Sloan Kettering Cancer Center
10:20 AM
The Role of the Intestinal Microbiome in Cancer Immunotherapy
Marcel van den Brink, MD, PhD, City of Hope
10:50 AM
Programmable Probiotics for Personalized Cancer Immunotherapy
Nicholas Arpaia, PhD, Columbia University
11:20 AM
Susan Bullman, PhD, MD Anderson Cancer Center